Generate a tailored SOP for Dr. Chad Brummett. Improve your application with a focused, well-structured draft.
Chad Brummett, MD, is a recognized leader in the field of anesthesiology at the University of Michigan Medical School. He holds the position of Bert N. LaDu Professor and serves as the Associate Chair for Research in the Department of Anesthesiology. Dr. Brummett’s expertise encompasses opioid use disorders and safe prescribing practices, with a focus on understanding the genetic factors contributing to persistent opioid use in patients following surgery. His recent work has explored the transdiagnostic markers of pain responses, particularly in arthritis and chronic pain syndromes, and has led to significant contributions to medium- and long-term postoperative care guidelines. Committed to mentoring the next generation of researchers, Dr. Brummett has been recognized with the MICHR Distinguished Clinical Translational Research Mentor Award. He is also actively involved in FDA studies on the effects of CBD in managing postoperative pain. His research has consistently received NIH funding, giving him the opportunity to lead innovative projects that have a substantial impact on patient care.
Admission for Biological Chemistry, Cellular and Molecular Biology, Human Genetics, Microbiology and Immunology, Pharmacology, Molecular and Integrative Physiology, Cancer Biology, and Neuroscience is primary handled through the PIBS (Program in Biomedical Sciences) gateway.